CCL2 and primary cutaneous T-cell non-Hodgkin lymphoma: The CCL2–CCR2 axis is implicated in macrophage recruitment in CTCL lesions, and preclinical studies suggest that CCR2 antagonism can reduce TAM enrichment and may synergize with immune checkpoint blockade in CTCL models [111].